DNANexus said recently that it has raised $15 million in a Series C financing round, and company officials told BioInform this week that the funds are earmarked for commercialization efforts and to scale up to better support global customers.

According to CEO Richard Daly, in 2013 the company "largely perfected the functionality that allows us to support customers' genomic data into the cloud" working in concert with large genomics centers, pharmaceutical companies, commercial test developers, and kit manufactures.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.